GMNPX | MLPDX | GMNPX / MLPDX | |
Total Expense Ratio | 6.62 | 9.02 | 73% |
Annual Report Gross Expense Ratio | 6.62 | 9.02 | 73% |
Fund Existence | 7 years | 15 years | - |
Gain YTD | 2.840 | 4.904 | 58% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.62B | 3.91B | 41% |
Annual Yield % from dividends | 6.59 | 7.25 | 91% |
Returns for 1 year | 10.44 | 12.14 | 86% |
Returns for 3 years | 62.95 | 64.79 | 97% |
Returns for 5 years | 219.24 | 246.53 | 89% |
Returns for 10 years | N/A | 96.68 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THISX | 81.02 | 0.71 | +0.88% |
T. Rowe Price Health Sciences I | |||
RSVYX | 26.83 | 0.06 | +0.22% |
Victory RS Value Y | |||
HWSAX | 76.96 | 0.13 | +0.17% |
Hotchkis & Wiley Small Cap Value A | |||
CDOZX | 41.05 | -0.06 | -0.15% |
Columbia Dividend Opportunity Inst | |||
BBISX | 33.91 | -0.16 | -0.47% |
Sterling Capital Behav Lg Cp Val Eq Intl |